Episode 8: Fostering dialogue between regulators like the European Medicines Agency (EMA) and the Hypo-RESOLVE project

https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/d5/92/a7/d592a74d-fc34-a359-ad52-911d2c3e8c21/mza_8566339458553141766.jpg/600x600bb.jpg

Patient Engagement in Research Initiatives: The Hypo-RESOLVE Approach

Hypo-RESOLVE

8 episodes

1 day ago

In this eight-episode series, we are shining a light on the value of patient engagement in general and the innovative way the Hypo-RESOLVE project approaches the involvement of people living with diabetes (PwD). Scientists, clinicians and members of our Patient Advisory Committee (PAC) discuss the progress in the different work areas of the project and give valuable insight into the experiences of including PwD in research initiatives from both perspectives.

Science

RSS

All content for Patient Engagement in Research Initiatives: The Hypo-RESOLVE Approach is the property of Hypo-RESOLVE and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_episode/10874862/10874862-1646745267174-8f764a920f354.jpg

Episode 8: Fostering dialogue between regulators like the European Medicines Agency (EMA) and the Hypo-RESOLVE project

Patient Engagement in Research Initiatives: The Hypo-RESOLVE Approach

23 minutes 26 seconds

3 years ago

Episode 8: Fostering dialogue between regulators like the European Medicines Agency (EMA) and the Hypo-RESOLVE project

Making sure that the Hypo-RESOLVE results change the diabetes (research) landscape for the better, is one of our most important goals. For our last episode, we have invited Jens Heisterberg from Novo Nordisk and Ken Tait from our Patient Advisory Committee (PAC) to talk about the importance of establishing a dialogue with government officials.